Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychological nursing and preservative-free oxybuprocaine during corneal refractive surgery
ChiCTR2500097357Phase 4Completed
- Sponsor
- Nanning Aier Eye Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxybuprocaine in ametropia (2 arms), sponsored by Nanning Aier Eye Hospital. Primary endpoint: Pain score at 5 minutes postoperatively. Started Feb 2025; status: completed.
02
Drugs
oxybuprocaine
03
Conditions
ametropia
Beyond the preview
Go deeper on ChiCTR2500097357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097357.